Antenatal corticosteroids (ACS) are an established therapy for pregnant women at risk of preterm birth. Researchers have found that babies given ACS had notably smaller volumes of two key brain regions, the bilateral amygdalae and caudate nuclei, which are essential for emotion processing and motor control, respectively. The findings suggest that doctors should adjust ACS use to reduce potential risks to brain development.